India's healthcare sector aims for $700 billion by 2030, facing financing and infrastructure challenges. Public-private partnerships are...
medical devices
India's drug regulator increases scrutiny of GLP-1 weight loss drugs due to unauthorized sales and improper prescriptions....
Delhi's healthcare sector expands with 1,288 new hospital beds and improved emergency response. Addressing rising demand and...
Indian drugmakers launch affordable generic versions of Ozempic & Wegovy, slashing costs by 70%. Increased access to...
Indian drugmakers compete for obesity market share as generic weight-loss drugs drive prices down, increasing access but...
Alkem Labs enters India's weight-loss market with Semaglutide injection, offering a cost-effective solution for diabetes and weight...
Dr. Reddy's Laboratories introduces Obeda, a semaglutide injectable, in India, enhancing their diabetes care portfolio. A new...
Dr. Reddy's Laboratories introduces 'Obeda', a semaglutide version for diabetes management in India. Aims to expand its...
Dr. Reddy's introduces Obeda, a generic semaglutide injection, the first DCGI-approved treatment for Type 2 diabetes in...
Helium supply disruptions in West Asia threaten MRI services in India, driving up costs for healthcare providers...
